Adam Kuspa
Chief Tech/Sci/R&D Officer at Baylor College of Medicine
Profile
Adam Kuspa is currently the Director at Diversigen, Inc., FGH Biotech, Inc., and Vice President-Research at Baylor College of Medicine.
He holds a doctorate degree from Stanford University and an undergraduate degree from the University of California San Diego.
Adam Kuspa active positions
| Companies | Position | Start |
|---|---|---|
Diversigen, Inc.
 Diversigen, Inc. Miscellaneous Commercial ServicesCommercial Services Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX. | Director/Board Member | - |
| Baylor College of Medicine | Chief Tech/Sci/R&D Officer | - |
FGH Biotech, Inc.
 FGH Biotech, Inc. Pharmaceuticals: MajorHealth Technology FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX. | Director/Board Member | - |
Training of Adam Kuspa
| Stanford University | Doctorate Degree |
| University of California San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Diversigen, Inc.
Diversigen, Inc. Miscellaneous Commercial ServicesCommercial Services Diversigen, Inc. provides microbiome and metagenomics services. The firm also offers data analysis, focused on solutions to improve human and animal health, environmental conditions and agriculture production worldwide. It offers metagenomics, single organism genome, microbial RNA, and viral metagenomics sequencing services. The company was founded by Joseph F. Petrosino in 2013 and is headquartered in Houston, TX. | Commercial Services |
FGH Biotech, Inc.
FGH Biotech, Inc. Pharmaceuticals: MajorHealth Technology FGH Biotech, Inc. is a drug discovery and development company that specializes in the development of drugs for the treatment of metabolic disorders. The firm's products are used in various treatment indications, such as obesity, non-alcoholic fatty liver disease, type II diabetes, lipid disorders, cardiovascular disease, and cancer therapy. The company was founded by Salih J. Wakil, Motonari Uesugi and Lutfi Abu-Elheiga in 2011 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Adam Kuspa
